We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTI:NYSETetra Technologies, Inc. Analysis

Data as of 2026-06-06 - not real-time

$9.29

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its 20‑day moving average but remains above the 50‑day line, suggesting a short‑term pullback within a longer bullish framework. RSI is hovering in the low‑40s, indicating modest downside momentum, while the MACD histogram is negative, pointing to bearish pressure despite an overall bullish trend and rising volume. High 30‑day volatility and a beta well above the market underscore a risk‑on profile.
Fundamental backdrop: Recent earnings beat expectations with a net income of $8.3 million and EPS surpassing forecasts, yet revenue growth is flat and margins are modest. Valuation appears stretched against peers (current P/E far above industry average) but forward metrics and analyst consensus imply upside, reinforced by a “strong buy” rating and a target price roughly 35% higher than the current level. The company carries significant debt and pays no dividend, limiting income appeal but offering potential capital appreciation in a recovery of oilfield services.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings beat but price below short‑term SMA
  • Negative MACD histogram signaling near‑term weakness
  • Elevated volatility and beta increasing downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings growth and improved EPS outlook
  • Analyst consensus strong‑buy with upside potential
  • Rising volume indicating accumulating interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic position in oilfield services as demand recovers
  • Long‑run upside to target price despite current valuation stretch
  • Strong cash flow generation relative to debt levels

Key Metrics & Analysis

Financial Health

Revenue Growth-0.60%
Profit Margin1.16%
P/E Ratio154.8
ROE3.04%
ROA5.20%
Debt/Equity78.55
P/B Ratio4.4
Op. Cash Flow$84.6M
Free Cash Flow$224.5K
Industry P/E30.2

Technical Analysis

TrendBullish
RSI40.4
Support$9.27
Resistance$11.00
MA 20$10.31
MA 50$9.51
MA 200$8.45
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Target Price$12.50
Upside/Downside34.55%
GradeFair
TypeBlend

Risk Assessment

Beta1.63
Volatility51.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.